Close Menu

NEW YORK (GenomeWeb) – Genomic Vision said today that it has signed an exclusive distribution agreement that will enable AmCare Genomics Laboratory to market its facioscapulohumeral muscular dystrophy diagnostic assay in China.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.